TAKEDA VENTURES

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance to entrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
TAKEDA VENTURES
Industry:
Finance Financial Services Health Diagnostics Therapeutics
Founded:
2001-01-01
Status:
Active
Contact:
(619) 930-8400
Technology used in webpage:
SPF DMARC Microsoft Exchange Online Office 365 Mail Amazon Route 53 CSC CDNS Network
Similar Organizations
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
More Disruption Please
Athenahealth's MDP focuses on accelerating health care entrepreneurs and startups.
Helomics
Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
Current Employees Featured
Michael Martin Head of Takeda Ventures, Inc. @ Takeda Ventures
Head of Takeda Ventures, Inc.
2015-01-01
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-10-27 | GammaDelta Therapeutics | GammaDelta Therapeutics acquired by Takeda Ventures | 100 M USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2024-10-22 | Be Biopharma | Takeda Ventures investment in Venture Round - Be Biopharma | 82 M USD |
2023-11-16 | EvolveImmune Therapeutics | Takeda Ventures investment in Venture Round - EvolveImmune Therapeutics | 37.4 M USD |
2023-05-23 | Larkspur Biosciences | Takeda Ventures investment in Series A - Larkspur Biosciences | 35.5 M USD |
2023-05-18 | OncoResponse | Takeda Ventures investment in Series D - OncoResponse | 14 M USD |
2023-02-13 | Cerevance | Takeda Ventures investment in Series B - Cerevance | 51 M USD |
2023-01-05 | Ensoma | Takeda Ventures investment in Series B - Ensoma | 85 M USD |
2022-11-04 | hC Bioscience | Takeda Ventures investment in Series A - hC Bioscience | 16 M USD |
2022-11-02 | Enzyre | Takeda Ventures investment in Series A - Enzyre | 12 M EUR |
2022-08-25 | Zelluna Immunotherapy | Takeda Ventures investment in Venture Round - Zelluna Immunotherapy | N/A |
2022-06-07 | Code Biotherapeutics | Takeda Ventures investment in Series A - Code Biotherapeutics | 75 M USD |
More informations about "Takeda Ventures"
Takeda Ventures, Inc. - LinkedIn
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. We ...See details»
Takeda Ventures - Crunchbase Investor Profile
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.See details»
Center for External Innovation | Takeda Pharmaceuticals
Takeda Ventures focuses on high-caliber, therapeutic, platform-based companies around the world. We specifically invest in early-stage, preclinical opportunities and products which complement Takeda’s pipeline with the mission to create …See details»
Takeda Ventures investment portfolio | PitchBook
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited based in Cambridge, Massachusetts.See details»
Takeda Ventures - Foreign Corporate VC | Startup Nation Finder
Dec 8, 2024 Takeda Ventures (TVI) is the corporate investment arm of Takeda Pharmaceuticals. It invests in current and future areas of interest for Takeda Pharmaceuticals. As a strategic …See details»
TAKEDA-VENTURES - flaia.org
Takeda Ventures: Innovating Life Science and Providing Strategic Growth Opportunities Established in 2001, Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda …See details»
Takeda Ventures, Inc. | VentureRadar
Takeda Ventures, Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Ltd, a global pharmaceutical company. The company encourages and supports therapeutic …See details»
Takeda Ventures - Massinvestor Venture Capital and Private Equity …
Takeda Ventures, Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Limited (TPC), a pharmaceutical company and the largest in Japan. TVI assumes the role of …See details»
Takeda Ventures, Inc. - venturecapitalarchive.com
Takeda Ventures, Inc. is the corporate venture Capital group of Takeda, founded in 2001, with a vision to generate disruptive technologies and therapeutic solutions through venturebased …See details»
Private Equity List | Takeda Ventures
Takeda's journey expands and advances the translation of science into highly innovative medicines while maintaining our agility as a global, values-based, R&D-driven, …See details»
List of top Takeda Ventures Portfolio Companies - Crunchbase
Jun 12, 2013 Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world. This list of organizations invested in by Takeda Ventures …See details»
Our R&D Partnering Program | Takeda Pharmaceuticals
Takeda Ventures, Inc. A part of CEI, Takeda Ventures is our corporate venture capital group that aims to create strategic growth opportunities by investing in and nurturing innovative life …See details»
Executive Leadership | Takeda Pharmaceuticals
The Takeda leadership team is committed to developing strategy and executing it in a way that puts the patient at the center of everything we do.See details»
Takeda Ventures - Investments, Portfolio & Company Exits
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.See details»
Leadership | Woodbridge
Our Executive Leadership Team brings their vast knowledge and experience together to create a strong and agile organization.See details»
Corporate Venturing - Harvard Business Review
Reprint: R1310D For decades, large companies have been wary of corporate venturing. But as R&D organizations face pressure to rein in costs and produce results, companies are investing …See details»
Corporate venture building for CEOs | McKinsey
Oct 22, 2024 Venture building starts with uncovering hidden treasures within an organization The latest survey results show that, for most companies, opportunity is ripe to build new …See details»
Takeda Ventures, Inc. - venturecapitalarchive.com
Takeda Ventures, Inc. is the corporate venture capital group of Takeda, founded in 2001, with a vision to generate disruptive technologies and therapeutic solutions through venture-based …See details»
Takeda, the Longest-Standing Corporate Partner of the Global …
1 day ago The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) welcomed a commitment of JPY 350 million from Takeda Pharmaceutical Company, a Japan …See details»
Board of Directors - WoodBridge Healthcare
The WoodBridge Healthcare team is comprised of dedicated healthcare professionals brings the experience, expertise and strategic insight to help healthcare organizations grow and thrive – …See details»